{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:28:18Z","timestamp":1774038498888,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.carrev.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T12:21:55Z","timestamp":1639052515000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials"],"prefix":"10.1016","volume":"40","author":[{"given":"Ashish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajkumar","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safi U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Shariff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeswin","family":"Baby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monil","family":"Majmundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmar","family":"Kanaa'N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh N.","family":"Khot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.12.005_bb0005","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/eurheartj\/ehw044","article-title":"Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a cardiac surgeon","volume":"37","author":"Holmes","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.12.005_bb0010","first-page":"e354","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.amjcard.2014.07.013","article-title":"Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011)","volume":"114","author":"Kim","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2021.12.005_bb0020","first-page":"53","article-title":"Appropriateness of percutaneous coronary intervention","volume":"306","author":"Chan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2021.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/jamainternmed.2020.3181","article-title":"Potential association of the ISCHEMIA trial with the appropriate use criteria ratings for percutaneous coronary intervention in stable ischemic heart disease","volume":"180","author":"Malik","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0030","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.12.005_bb0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0735-1097(00)01191-8","article-title":"Prediction of mortality using dobutamine echocardiography","volume":"37","author":"Marwick","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.12.005_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"PAL","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.120.048194","article-title":"Routine revascularization versus initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials","volume":"142","author":"Bangalore","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.12.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.1647","article-title":"Bayesian interpretation of the EXCEL trial and other randomized clinical trials of left main coronary artery revascularization","author":"Brophy","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.319.7208.508","article-title":"Methods in health service research. An introduction to Bayesian methods in health technology assessment","volume":"319","author":"Spiegelhalter","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2021.12.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2021.12.005_bb0065","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1161\/CIR.0000000000000523","article-title":"Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart Association","volume":"136","author":"Rao","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.12.005_bb0070","first-page":"57","article-title":"Systematic reviews and meta-analyses","volume":"20","author":"Uman","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.carrev.2021.12.005_bb0075","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.carrev.2021.12.005_bb0080","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v080.i01","article-title":"brms: an R package for Bayesian multilevel models using Stan","volume":"1","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"issue":"1","key":"10.1016\/j.carrev.2021.12.005_bb0085","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v076.i01","article-title":"Stan: a probabilistic programming language","volume":"1","author":"Carpenter","year":"2017","journal-title":"J Stat Softw"},{"key":"10.1016\/j.carrev.2021.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0100","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0105","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2021.12.005_bb0115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2003.08.065","article-title":"The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results","volume":"43","author":"Hueb","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.12.005_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcin.2008.08.002","article-title":"Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease: a randomized, comparative, multicenter study","volume":"1","author":"Nishigaki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.12.005_bb0125","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ahj.2013.09.008","article-title":"Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry","volume":"166","author":"Bangalore","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2021.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0735-1097(02)01877-6","article-title":"Prognostic significance of elevated troponin i after percutaneous coronary intervention","volume":"39","author":"Cantor","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.12.005_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCINTERVENTIONS.108.765610","article-title":"Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention","volume":"1","author":"Prasad","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/erc.12.78","article-title":"Stroke in patients undergoing coronary angiography and percutaneous coronary intervention: incidence, predictors, outcome and therapeutic options","volume":"10","author":"Werner","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.carrev.2021.12.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013032","article-title":"Stroke after coronary artery bypass grafting and percutaneous coronary intervention: incidence, pathogenesis, and outcomes","volume":"8","author":"Gaudino","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2021.12.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008565","article-title":"Long-term outcomes after revascularization for stable ischemic heart disease","volume":"13","author":"Madhavan","year":"2020","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921007788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921007788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:24:50Z","timestamp":1761560690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921007788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":30,"alternative-id":["S1553838921007788"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.12.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}